Nervgen Pharma NGEN
NASDAQ NGEN
$1.86 +0.10 (+5.68%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Interest & Investment Income (2025 - 2026)

Nervgen Pharma (NGEN) posted quarterly Interest & Investment Income of -$75886.2 for Q1 2026, down 201.05% year-over-year from $75100.4 in Q1 2025, and down 201.05% quarter-over-quarter from $75100.4 in Q1 2025.

Nervgen Pharma (NGEN) Interest & Investment Income (2025 - 2026) Analysis & Trends

Nervgen Pharma (NGEN) has reported Interest & Investment Income for 2 consecutive years, with -$75886.2 the latest figure, recorded in Q1 2026.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 67.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 27.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 28.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 115.94 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 10.98 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 5.13 Mn
10 Nervgen Pharma 168.94 Mn 168.94 Mn - -130,451.87

Historic Data

Download Data
DateValue
Mar 31, 2026 -75,886.25
Mar 31, 2025 75,100.42